Generic Tekamlo

At this time, generic Tekamlo (aliskiren/amlodipine) is not available. The earliest a generic version could be expected is July 2018, when the patent for this medication expires. In the meantime, Tekamlo can still offer a financial benefit for people taking the individual components of this drug separately. By combining these two ingredients into one tablet, the cost to treat high blood pressure could be reduced.

Tekamlo Medication Information

Can I Buy Generic Tekamlo?

Tekamlo™ (aliskiren/amlodipine) is a prescription medication approved to treat high blood pressure (hypertension). It contains two different medications: aliskiren (Tekturna^®) and amlodipine (Norvasc^®). Amlodipine is classified as a calcium channel blocker, and aliskiren is classified as a renin inhibitor.

Tekamlo is made by Novartis Pharmaceuticals Corporation. It is currently under the protection of a patent that prevents any generic versions from being manufactured in the United States.

When Will Generic Tekamlo Be Available?

The first patent for this aliskiren component of this drug is set to expire in July 2018. There are no unexpired patents for the amlodipine. Therefore, July 2018 is the earliest predictable date that a generic version of Tekamlo could become available.

However, other circumstances could come up to extend or shorten the exclusivity period. This could include such things as other patents for specific Tekamlo uses or lawsuits.

The Benefits of Tekamlo

As stated previously, Tekamlo contains two different medications.

Although amlodipine is available in generic form, aliskiren is not. For many people (depending on insurance coverage), it is less expensive to take Tekamlo rather than the two medications separately, and you will benefit from the convenience of taking one tablet daily, rather than two.